2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1437224946 MD
Verify on CMS →

MARIA FERNANDEZ RENEDO, MD

Endocrinology, Diabetes & Metabolism Physician in MERCED, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
686
Medicare Part D claims · 99 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
70%
generic claims · 30% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MARIA FERNANDEZ RENEDO, MD filed 686 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in MERCED, California, prescribing 70% generic.

686
Part D claims, 2023
70%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARIA FERNANDEZ RENEDO, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

686 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MARIA FERNANDEZ RENEDO, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARIA FERNANDEZ RENEDO, MD?

Quality data not reported

NPI registry status

Active

Issued 11/21/2006

NPI 1437224946

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

686 74% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in California

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers

California providers

Endocrinology, Diabetes & Metabolism Physician share within California

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARIA FERNANDEZ RENEDO, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 750 W OLIVE AVE, MERCED, CA, 95348, with a listed phone of (209) 723-0011. NPI 1437224946 was issued on 11/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FERNANDEZ RENEDO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 686 prescription claims written by this provider, covering 99 Medicare beneficiaries and totaling roughly $137K in drug spend, split 30% brand-name and 70% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

750 W OLIVE AVE
MERCED, CA 95348

Provider Details

NPI 1437224946
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 11/21/2006

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARIA FERNANDEZ RENEDO, MD. To verify MARIA FERNANDEZ RENEDO, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MARIA FERNANDEZ RENEDO, MD — brand share 30.0%
Specialty average (est.)

30% brand-name claims vs 70% generic, on 686 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

686
Total Claims
$137K
Total Drug Cost
99
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,569
Total Day Supply
46,800
Brand vs Generic
30% brand / 70% generic
Brand Drug Cost
$125K
Generic Drug Cost
$11K

Patient Demographics

Average Patient Age
72.2 years
Avg HCC Risk Score
1.13
Gender Split
78% female / 22% male
Age Distribution
<65: 11, 65-74: 51, 75-84: 24, 85+: 13

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARIA FERNANDEZ RENEDO, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
289
Methimazole
32
Metformin Hcl
27
Glipizide
26
Jardiance
Empagliflozin
21
Alendronate Sodium
20
Humalog
Insulin Lispro
17
Ozempic
Semaglutide
16
Pioglitazone Hcl
16
Testosterone Cypionate
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How MARIA FERNANDEZ RENEDO, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

MARIA FERNANDEZ RENEDO, MD's 686 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as FERNANDEZ RENEDO.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARIA FERNANDEZ RENEDO, MD's specialty?
MARIA FERNANDEZ RENEDO, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MERCED, California. Credentials: MD.
How much does MARIA FERNANDEZ RENEDO, MD prescribe under Medicare Part D?
In 2023, MARIA FERNANDEZ RENEDO, MD wrote 686 Medicare Part D claims totaling $137K in drug costs for 99 beneficiaries.
Where is MARIA FERNANDEZ RENEDO, MD located?
MARIA FERNANDEZ RENEDO, MD is located at 750 W OLIVE AVE, MERCED, CA, 95348. Phone: (209) 723-0011.
What is MARIA FERNANDEZ RENEDO, MD's NPI number?
MARIA FERNANDEZ RENEDO, MD's National Provider Identifier (NPI) is 1437224946, issued on 11/21/2006.
Does MARIA FERNANDEZ RENEDO, MD prescribe more brand-name or generic drugs?
MARIA FERNANDEZ RENEDO, MD's prescribing is 30% brand-name and 70% generic drugs by claim count, with $125K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does MARIA FERNANDEZ RENEDO, MD prescribe most often?
Based on 2023 Medicare Part D data, MARIA FERNANDEZ RENEDO, MD's most frequently prescribed drugs include Levothyroxine Sodium, Methimazole, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARIA FERNANDEZ RENEDO, MD accept Medicare?
MARIA FERNANDEZ RENEDO, MD appears in CMS Medicare data with 686 Part D claims and 99 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARIA FERNANDEZ RENEDO, MD's credentials?
MARIA FERNANDEZ RENEDO, MD's NPI is 1437224946 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology